IDH2 and astrocytoma (excluding glioblastoma): The relatively shorter PFS and OS of patients with diffuse astrocytoma and anaplastic astrocytoma in the current study were probably attributable to the fact that the present cohort included more patients with IDH wild-type astrocytoma than the previous study.